Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results